TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Once-daily dolutegravir sufficient when taking TB treatment

A second daily dose of dolutegravir for people taking standard TB treatment seems to be unnecessary, a South African randomised study has reported in the journal Lancet HIV.

Read the full article at Aidsmap.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Keith Alcorn

Published: June 16, 2023, 1:37 p.m.

Last updated: June 20, 2023, 12:47 p.m.

Print Share